Get a Quote

Anastrozole API | CAS# 120511-73-1
CAS NO.: 120511-73-1
Chemical Formula: C23H31N3O4S2
Molecular Weight: 293.3663
DMF&GMP status: Please contact us for more details.
Description:
Anastrozole lowers estrogen levels in postmenopausal women, which may slow the growth of certain types of breast tumors that need estrogen to grow in the body.

Anastrozole is used to treat breast cancer in postmenopausal women. It is often given to women whose cancer has progressed even after taking tamoxifen (Nolvadex, Soltamox).
Approvals
Active Ingredient Dosage Form; Route Strength Proprietary Name Applicant
ANASTROZOLETABLET; ORAL1MGANASTROZOLEACCORD HLTHCARE
ANASTROZOLE TABLET; ORAL 1MG ANASTROZOLE APOTEX INC
ANASTROZOLE TABLET; ORAL 1MG ANASTROZOLE CIPLA LTD
ANASTROZOLE TABLET; ORAL 1MG ANASTROZOLE DR REDDYS LABS LTD
ANASTROZOLE TABLET; ORAL 1MG ANASTROZOLE FRESENIUS KABI ONCOL
ANASTROZOLE TABLET; ORAL 1MG ANASTROZOLE MYLAN
ANASTROZOLE TABLET; ORAL 1MG ANASTROZOLE NATCO PHARMA LTD
ANASTROZOLE TABLET; ORAL 1MG ANASTROZOLE ROXANE
ANASTROZOLE TABLET; ORAL 1MG ANASTROZOLE SANDOZ
ANASTROZOLE TABLET; ORAL 1MG ANASTROZOLE SANTOS BIOTECH
ANASTROZOLE TABLET; ORAL 1MG ANASTROZOLE SUN PHARM INDS LTD
ANASTROZOLE TABLET; ORAL 1MG ANASTROZOLE TEVA PHARMS
ANASTROZOLE TABLET; ORAL 1MG ANASTROZOLE ZYDUS PHARMS USA INC
Patent Data
Patent No. Patent Expiration Drug Substance Claim Drug Product Claim Patent Use Code
Exclusive Data
Exclusivity Code Exclusivity Expiration